To determine whether GILZ repression affects tumour formation in vivo, we knocked down GILZ expression in B16F1-GFP-D dormant DMC-derived cells and B16F1-GFP-M maternal cells using siRNA technology. The gene discussed is TSC22D3; the disease is neoplasm.